|
1
|
Kevin P, Becker, Yu J, et al: Status quo -
standard-of-care medical and radiation therapy for glioblastoma.
Cancer J. 18:12–19. 2012. View Article : Google Scholar
|
|
2
|
Yang P, Wang Y, Peng X, et al: Management
and survival rates in patients with glioma in China (2004–2010): a
retrospective study from a single-institution. J Neurooncol.
2:259–266. 2013. View Article : Google Scholar
|
|
3
|
Aggarwal BB, Bhardwaj A, Aggarwal RS, et
al: Role of resveratrol in prevention and therapy of cancer:
preclinical and clinical studies. Anticancer Res. 24:2783–2840.
2004.PubMed/NCBI
|
|
4
|
Cao Y, Wang F, Liu HY, et al: Resveratrol
induces apoptosis and differentiation in acute promyelocytic
leukemia (NB4) cells. J Asian Nat Prod Res. 7:633–641. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De la Lastra CA and Villegas I:
Resveratrol as an anti-inflammatory and anti-aging agent:
mechanisms and clinical implications. Mol Nutr Food Res.
49:405–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castello L and Tessitore L: Resveratrol
inhibits cell cycle progression in U937 cells. Oncol Rep.
13:133–137. 2005.
|
|
7
|
Gao X, Xu YX, Divine G, et al: Disparate
in vitro and in vivo antileukemic effects of resveratrol, a natural
polyphenolic compound found in grapes. J Nutr. 132:2076–2081.
2002.PubMed/NCBI
|
|
8
|
Jang M, Cai L, Udeani GO, et al: Cancer
chemopreventive activity of resveratrol, a natural product derived
from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gagliano N, Moscheni C, Torri C, et al:
Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and
Secreted Protein Acidic and Rich in Cysteine (SPARC) on human
cultured glioblastoma cells. Biomed Pharmacother. 59:359–364. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Zhang L, Kuo J, et al:
Resveratrol-induced apoptotic death in human U251 glioma cells. Mol
Cancer Ther. 4:554–561. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tseng SH, Lin SM, Chen JC, et al:
Resveratrol suppresses the angiogenesis and tumor growth of gliomas
in rats. Clin Cancer Res. 10:2190–2202. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang YP, Chang YL, Huang PI, et al:
Resveratrol suppresses tumorigenicity and enhances radiosensitivity
in primary glioblastoma tumor initiating cells by inhibiting the
STAT3 axis. J Cell Physiol. 227:976–993. 2012. View Article : Google Scholar
|
|
13
|
Zhang W, Wang YE, Zhang Y, et al: Global
epigenetic regulation of microRNAs in multiple myeloma. PLoS One.
9:e1109732014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tuomarila M, Luostari K, Soini Y, et al:
Overexpression of microRNA-200c predicts poor outcome in patients
with PR-negative breast cancer. PLoS One. 9:e1095082014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang KY, Ma J, Zhang FX, et al:
MicroRNA-378 inhibits cell growth and enhances l-OHP-induced
apoptosis in human colorectal cancer. IUBMB Life. 66:645–654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Q, Yang L, Xiao Y, et al: Circulating
microRNA-182 in plasma and its potential diagnostic and prognostic
value for pancreatic cancer. Med Oncol. 31:2252014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Yiwei, Kong Dejuan, Wang Zhiwei, et al:
Regulation of microRNAs by natural agents: an emerging field in
chemoprevention and chemotherapy research. Pharm Res. 27:1027–1041.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melkamu T, Zhang X, Tan J, et al:
Alteration of microRNA expression in vinyl-carbamateinduced mouse
lung tumors and modulation by the chemopreventive agent
indole-3-carbinol. Carcinogenesis. 31:252–258. 2010. View Article : Google Scholar
|
|
20
|
Li Y, VandenBoom TG, Kong D, et al:
Up-regulation of miR-200 and let-7 by natural agents leads to the
reversal of epithelial-to-mesenchymal transition in
gemcitabine-resistant pancreatic cancer cells. Cancer Res.
69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun M, Estrov Z, Ji Y, et al: Curcumin
(diferuloylmethane) alters the expression profiles of microRNAs in
human pancreatic cancer cells. Mol Cancer Ther. 7:464–473. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia Z, Wang K, Wang G, et al: MiR-30a-5p
antisense oligonucleotide suppresses glioma cell growth by
targeting SEPT7. PLoS One. 8:e550082013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia Z, Wang K, Zhang A, et al: MiR-19a and
miR-19b overexpression in gliomas. Pathol Oncol Res. 19:847–853.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Ren Y, Moore L, et al:
Downregulation of miR-21 inhibits EGFR pathway and suppresses the
growth of human glioblastoma cells independent of PTEN status. Lab
Invest. 90:144–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pu P, Liu X, Liu A, et al: Inhibitory
effect of antisense epidermal growth factor receptor RNA on the
proliferation of rat C6 glioma cells in vitro and in vivo. J
Neurosurg. 92:132–139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pu P, Kang C, Li J, et al: The effects of
antisense AKT2 RNA on the inhibition of malignant glioma cell
growth in vitro and in vivo. J Neurooncol. 76:1–11. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bove K, Lincoln DW and Tsan MF: Effect of
resveratrol on growth of 4T1 breast cancer cells in vitro and in
vivo. Biochem Biophys Res Commun. 291:1001–1005. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuwajerwala N, Cifuentes E, Gautam S, et
al: Resveratrol induces prostate cancer cell entry into S phase and
inhibits DNA synthesis. Cancer Res. 62:2488–2492. 2002.PubMed/NCBI
|
|
29
|
Kim YA, Lim SY, Rhee SH, et al:
Resveratrol inhibits inducible nitric oxide synthase and
cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma
cells. Int J Mol Med. 17:1069–1075. 2006.PubMed/NCBI
|
|
30
|
Tili E, Michaille JJ, Alder H, et al:
Resveratrol modulates the levels of microRNAs targeting genes
encoding tumor-suppressors and effectors of TGFβ signaling pathway
in SW480 cells. Biochem Pharmacol. 80:2057–2065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sheth S, Jajoo S, Kaur T, et al:
Resveratrol reduces prostate cancer growth and metastasis by
inhibiting the Akt/MicroRNA-21 pathway. PLoS One. 7:e516552012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krichevsky AM and Gabriely G: miR-21: a
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu S, Wu H, Wu F, et al: MicroRNA-21
targets tumor suppressor genes in invasion and metastasis. Cell
Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang F, Li T, Zhang B, et al:
MicroRNA-19a/b regulates multidrug resistance in human gastric
cancer cells by targeting PTEN. Biochem Biophys Res Commun.
434:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zawrocki A and Biernat W: Epidermal growth
factor receptor in glioblastoma. Folia Neuropathol. 43:123–132.
2005.PubMed/NCBI
|
|
37
|
Pu P, Kang C, Zhang Z, et al:
Downregulation of PIK3CB by siRNA suppresses malignant glioma cell
growth in vitro and in vivo. Technol Cancer Res Treat. 5:271–280.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gürsel DB, Connell-Albert YS, Tuskan RG,
et al: Control of proliferation in astrocytoma cells by the
receptor tyrosine kinase/PI3K/AKT signaling axis and the use of
PI-103 and TCN as potential anti-astrocytoma therapies. Neuro
Oncol. 13:610–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ruano Y, Mollejo M, Camacho FI, et al:
Identification of survival-related genes of the
phosphatidylinositol 3′-kinase signaling pathway in glioblastoma
multiforme. Cancer. 112:1575–1584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang CS, Pu PY, Li YH, et al: An in vitro
study on the suppressive effect of glioma cell growth induced by
plasmid-based small interference RNA (siRNA) targeting human
epidermal growth factor receptor. J Neurooncol. 74:267–273. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brantley EC and Benveniste EN: Signal
transducer and activator of transcription-3: a molecular hub for
signaling pathways in gliomas. Mol Cancer Res. 6:675–684. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Germain D and Frank DA: Targeting the
cytoplasmic and nuclear functions of signal transducers and
activators of transcription 3 for cancer therapy. Clin Cancer Res.
13:5665–5669. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Quoc Trung L, Espinoza JL, Takami A, et
al: Resveratrol induces cell cycle arrest and apoptosis in
malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS One.
8:e551832013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Han L, Yue X, Zhou X, et al: MicroRNA-21
expression is regulated by β-catenin/STAT3 pathway and promotes
glioma cell invasion by direct targeting RECK. CNS Neurosci Ther.
18:573–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sminia P, Stoter TR, van der Valk P, et
al: Expression of cyclooxygenase-2 and epidermal growth factor
receptor in primary and recurrent glioblastoma multiforme. J Cancer
Res Clin Oncol. 131:653–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Banerjee S, Bueso-Ramos C and Aggarwal BB:
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary
carcinogenesis in rats by resveratrol: role of nuclear
factor-kappaB, cyclooxygenase-2, and matrix metalloprotease 9.
Cancer Res. 62:4945–4954. 2002.PubMed/NCBI
|
|
47
|
Ji Q, Liu X, Fu X, et al: Resveratrol
inhibits invasion and metastasis of colorectal cancer cells via
MALAT1 mediated Wnt/β-catenin signal pathway. PLoS One.
8:e787002013. View Article : Google Scholar
|
|
48
|
Pu P, Zhang Z, Kang C, et al:
Downregulation of Wnt2 and beta-catenin by siRNA suppresses
malignant glioma cell growth. Cancer Gene Ther. 16:351–361. 2009.
View Article : Google Scholar
|
|
49
|
Filippi-Chiela EC, Thomé MP, Bueno e Silva
MM, et al: Resveratrol abrogates the temozolomide-induced G2 arrest
leading to mitotic catastrophe and reinforces the
temozolomide-induced senescence in glioma cells. BMC Cancer.
22:1472013. View Article : Google Scholar
|
|
50
|
Nakada M, Furuta T, Hayashi Y, et al: The
strategy for enhancing temozolomide against malignant glioma. Front
Oncol. 2:982012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huang H, Lin H, Zhang X, et al:
Resveratrol reverses temozolomide resistance by downregulation of
MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Oncol Rep. 27:2050–2056. 2012.PubMed/NCBI
|
|
52
|
Yuan Y, Xue X, Guo RB, et al: Resveratrol
enhances the antitumor effects of temozolomide in glioblastoma via
ROS-dependent AMPK-TSC-mTOR signaling pathway. CNS Neurosci Ther.
18:536–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gagliano N, Aldini G, Colombo G, et al:
The potential of resveratrol against human gliomas. Anticancer
Drugs. 21:140–150. 2010. View Article : Google Scholar
|
|
54
|
Iguchi K, Toyama T, Ito T, et al:
Antiandrogenic activity of resveratrol analogs in prostate cancer
LNCaP cells. J Androl. 33:1208–1215. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Szekeres T, Saiko P and Fritzer-Szekeres
M: Chemopreventive effects of resveratrol and resveratrol
derivatives. Ann NY Acad Sci. 1215:89–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
